Stay updated on Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial
Sign up to get notified when there's something new on the Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial page.

Latest updates to the Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial page
- Check5 days agoChange DetectedThe study page gains new help sections (How to Read a Study Record, Common Questions, How to Join a Study) and shows that enrollment is closed, while the Intervention/Treatment header formatting is updated and the page revision is bumped to v3.6.0.SummaryDifference0.4%

- Check12 days agoChange DetectedA new revision tag (v3.5.5) was added and the previous tag (v3.5.4) removed, signaling a recent deployment update of the page.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page revision indicator was updated from v3.5.3 to v3.5.4, signaling a minor administrative update to the page version. No substantive content changes are introduced by this update.SummaryDifference0.0%

- Check55 days agoChange DetectedThe page’s footer revision/version number was updated from v3.5.2 to v3.5.3, reflecting a minor site release rather than a change to the study record itself.SummaryDifference0.0%

- Check62 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check91 days agoChange DetectedAdded revision tag v3.5.0 and removed revision tag v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial page.